nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2C8—Mometasone—systemic scleroderma	0.111	0.152	CbGbCtD
Rosiglitazone—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.104	0.143	CbGbCtD
Rosiglitazone—ALB—Captopril—systemic scleroderma	0.0727	0.0997	CbGbCtD
Rosiglitazone—CYP1A2—Pentoxifylline—systemic scleroderma	0.0581	0.0797	CbGbCtD
Rosiglitazone—ALB—Mycophenolate mofetil—systemic scleroderma	0.0572	0.0785	CbGbCtD
Rosiglitazone—CYP1A2—Leflunomide—systemic scleroderma	0.0554	0.076	CbGbCtD
Rosiglitazone—CYP2C9—Leflunomide—systemic scleroderma	0.0499	0.0685	CbGbCtD
Rosiglitazone—ALB—Prednisone—systemic scleroderma	0.0457	0.0627	CbGbCtD
Rosiglitazone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0442	0.0606	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—systemic scleroderma	0.0419	0.0575	CbGbCtD
Rosiglitazone—CYP2D6—Captopril—systemic scleroderma	0.0358	0.0491	CbGbCtD
Rosiglitazone—CYP2C19—Prednisone—systemic scleroderma	0.0297	0.0407	CbGbCtD
Rosiglitazone—ALB—Methotrexate—systemic scleroderma	0.0229	0.0315	CbGbCtD
Rosiglitazone—CYP2C9—cardial valve—systemic scleroderma	0.0171	0.219	CbGeAlD
Rosiglitazone—PPARG—dermis—systemic scleroderma	0.0121	0.156	CbGeAlD
Rosiglitazone—PPARG—artery—systemic scleroderma	0.00438	0.0562	CbGeAlD
Rosiglitazone—ACSL4—connective tissue—systemic scleroderma	0.00389	0.0499	CbGeAlD
Rosiglitazone—PPARG—endothelium—systemic scleroderma	0.0037	0.0475	CbGeAlD
Rosiglitazone—PPARG—blood vessel—systemic scleroderma	0.00341	0.0438	CbGeAlD
Rosiglitazone—ACSL4—digestive system—systemic scleroderma	0.00281	0.036	CbGeAlD
Rosiglitazone—ACSL4—tendon—systemic scleroderma	0.00267	0.0343	CbGeAlD
Rosiglitazone—ACSL4—lung—systemic scleroderma	0.00234	0.0301	CbGeAlD
Rosiglitazone—PTGS1—artery—systemic scleroderma	0.00234	0.0301	CbGeAlD
Rosiglitazone—PTGS1—endothelium—systemic scleroderma	0.00198	0.0254	CbGeAlD
Rosiglitazone—PTGS1—blood vessel—systemic scleroderma	0.00182	0.0234	CbGeAlD
Rosiglitazone—PPARG—connective tissue—systemic scleroderma	0.00175	0.0225	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—systemic scleroderma	0.0016	0.0205	CbGeAlD
Rosiglitazone—PPARG—skin of body—systemic scleroderma	0.00158	0.0203	CbGeAlD
Rosiglitazone—SLCO1B1—digestive system—systemic scleroderma	0.00146	0.0188	CbGeAlD
Rosiglitazone—PPARG—digestive system—systemic scleroderma	0.00126	0.0162	CbGeAlD
Rosiglitazone—CYP2A6—lung—systemic scleroderma	0.00124	0.0159	CbGeAlD
Rosiglitazone—PPARG—tendon—systemic scleroderma	0.0012	0.0154	CbGeAlD
Rosiglitazone—PPARG—lung—systemic scleroderma	0.00105	0.0135	CbGeAlD
Rosiglitazone—CYP2C19—digestive system—systemic scleroderma	0.000954	0.0122	CbGeAlD
Rosiglitazone—PTGS1—connective tissue—systemic scleroderma	0.000935	0.012	CbGeAlD
Rosiglitazone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000855	0.011	CbGeAlD
Rosiglitazone—PTGS1—skin of body—systemic scleroderma	0.000844	0.0108	CbGeAlD
Rosiglitazone—CYP1A2—digestive system—systemic scleroderma	0.000779	0.01	CbGeAlD
Rosiglitazone—CYP2C9—digestive system—systemic scleroderma	0.00074	0.0095	CbGeAlD
Rosiglitazone—PTGS1—digestive system—systemic scleroderma	0.000675	0.00867	CbGeAlD
Rosiglitazone—Weight increased—Lisinopril—systemic scleroderma	0.000668	0.00346	CcSEcCtD
Rosiglitazone—Anaemia—Captopril—systemic scleroderma	0.000667	0.00346	CcSEcCtD
Rosiglitazone—Infection—Mometasone—systemic scleroderma	0.000667	0.00345	CcSEcCtD
Rosiglitazone—Constipation—Pentoxifylline—systemic scleroderma	0.000665	0.00344	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000662	0.00343	CcSEcCtD
Rosiglitazone—Angioedema—Captopril—systemic scleroderma	0.00066	0.00342	CcSEcCtD
Rosiglitazone—Fluid retention—Prednisone—systemic scleroderma	0.00066	0.00342	CcSEcCtD
Rosiglitazone—Immune system disorder—Azathioprine—systemic scleroderma	0.000654	0.00339	CcSEcCtD
Rosiglitazone—Hepatitis—Mycophenolic acid—systemic scleroderma	0.000652	0.00338	CcSEcCtD
Rosiglitazone—CYP1A2—lung—systemic scleroderma	0.000651	0.00836	CbGeAlD
Rosiglitazone—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000649	0.00336	CcSEcCtD
Rosiglitazone—Erythema multiforme—Leflunomide—systemic scleroderma	0.000646	0.00335	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.000645	0.00334	CcSEcCtD
Rosiglitazone—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000643	0.00333	CcSEcCtD
Rosiglitazone—PTGS1—tendon—systemic scleroderma	0.000643	0.00825	CbGeAlD
Rosiglitazone—Myocardial infarction—Lisinopril—systemic scleroderma	0.000642	0.00332	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Mycophenolic acid—systemic scleroderma	0.000641	0.00332	CcSEcCtD
Rosiglitazone—Eye disorder—Leflunomide—systemic scleroderma	0.000639	0.00331	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—systemic scleroderma	0.000639	0.00331	CcSEcCtD
Rosiglitazone—Cardiac disorder—Leflunomide—systemic scleroderma	0.000635	0.00329	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000619	0.00321	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Prednisone—systemic scleroderma	0.000618	0.0032	CcSEcCtD
Rosiglitazone—Urticaria—Pentoxifylline—systemic scleroderma	0.000618	0.0032	CcSEcCtD
Rosiglitazone—Immune system disorder—Leflunomide—systemic scleroderma	0.000618	0.0032	CcSEcCtD
Rosiglitazone—Arthralgia—Captopril—systemic scleroderma	0.000615	0.00318	CcSEcCtD
Rosiglitazone—Myalgia—Captopril—systemic scleroderma	0.000615	0.00318	CcSEcCtD
Rosiglitazone—Sinusitis—Lisinopril—systemic scleroderma	0.000614	0.00318	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—systemic scleroderma	0.000614	0.00318	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000611	0.00317	CcSEcCtD
Rosiglitazone—Eye disorder—Mycophenolic acid—systemic scleroderma	0.00061	0.00316	CcSEcCtD
Rosiglitazone—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000605	0.00314	CcSEcCtD
Rosiglitazone—Malnutrition—Leflunomide—systemic scleroderma	0.000595	0.00308	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Captopril—systemic scleroderma	0.000589	0.00305	CcSEcCtD
Rosiglitazone—Hepatitis—Lisinopril—systemic scleroderma	0.000588	0.00304	CcSEcCtD
Rosiglitazone—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00303	CcSEcCtD
Rosiglitazone—Anaemia—Azathioprine—systemic scleroderma	0.000583	0.00302	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00058	0.003	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Prednisone—systemic scleroderma	0.00058	0.003	CcSEcCtD
Rosiglitazone—Oedema peripheral—Lisinopril—systemic scleroderma	0.000579	0.003	CcSEcCtD
Rosiglitazone—Fatigue—Mometasone—systemic scleroderma	0.000579	0.003	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Captopril—systemic scleroderma	0.000577	0.00299	CcSEcCtD
Rosiglitazone—Back pain—Leflunomide—systemic scleroderma	0.000576	0.00298	CcSEcCtD
Rosiglitazone—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000568	0.00294	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00293	CcSEcCtD
Rosiglitazone—Leukopenia—Azathioprine—systemic scleroderma	0.000564	0.00292	CcSEcCtD
Rosiglitazone—PTGS1—lung—systemic scleroderma	0.000564	0.00724	CbGeAlD
Rosiglitazone—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.000562	0.00291	CcSEcCtD
Rosiglitazone—Asthenia—Pentoxifylline—systemic scleroderma	0.000558	0.00289	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Prednisone—systemic scleroderma	0.000556	0.00288	CcSEcCtD
Rosiglitazone—Erythema multiforme—Lisinopril—systemic scleroderma	0.000555	0.00288	CcSEcCtD
Rosiglitazone—CYP2D6—digestive system—systemic scleroderma	0.000555	0.00713	CbGeAlD
Rosiglitazone—Pruritus—Pentoxifylline—systemic scleroderma	0.00055	0.00285	CcSEcCtD
Rosiglitazone—Anaemia—Leflunomide—systemic scleroderma	0.00055	0.00285	CcSEcCtD
Rosiglitazone—Back pain—Mycophenolic acid—systemic scleroderma	0.000549	0.00284	CcSEcCtD
Rosiglitazone—Angioedema—Leflunomide—systemic scleroderma	0.000544	0.00282	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00281	CcSEcCtD
Rosiglitazone—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000538	0.00279	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000537	0.00278	CcSEcCtD
Rosiglitazone—Increased appetite—Prednisone—systemic scleroderma	0.000537	0.00278	CcSEcCtD
Rosiglitazone—Myalgia—Azathioprine—systemic scleroderma	0.000537	0.00278	CcSEcCtD
Rosiglitazone—Arthralgia—Azathioprine—systemic scleroderma	0.000537	0.00278	CcSEcCtD
Rosiglitazone—Leukopenia—Leflunomide—systemic scleroderma	0.000533	0.00276	CcSEcCtD
Rosiglitazone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000532	0.00276	CcSEcCtD
Rosiglitazone—Anaemia—Mycophenolic acid—systemic scleroderma	0.000525	0.00272	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—systemic scleroderma	0.000517	0.00268	CcSEcCtD
Rosiglitazone—Cardiac failure—Prednisone—systemic scleroderma	0.000517	0.00268	CcSEcCtD
Rosiglitazone—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000515	0.00267	CcSEcCtD
Rosiglitazone—Dizziness—Pentoxifylline—systemic scleroderma	0.000514	0.00266	CcSEcCtD
Rosiglitazone—Hypertension—Leflunomide—systemic scleroderma	0.000514	0.00266	CcSEcCtD
Rosiglitazone—Malnutrition—Lisinopril—systemic scleroderma	0.000511	0.00265	CcSEcCtD
Rosiglitazone—Infection—Azathioprine—systemic scleroderma	0.000511	0.00265	CcSEcCtD
Rosiglitazone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000508	0.00263	CcSEcCtD
Rosiglitazone—Fatigue—Captopril—systemic scleroderma	0.000508	0.00263	CcSEcCtD
Rosiglitazone—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00263	CcSEcCtD
Rosiglitazone—Arthralgia—Leflunomide—systemic scleroderma	0.000507	0.00262	CcSEcCtD
Rosiglitazone—Myalgia—Leflunomide—systemic scleroderma	0.000507	0.00262	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00262	CcSEcCtD
Rosiglitazone—Constipation—Captopril—systemic scleroderma	0.000504	0.00261	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000504	0.00261	CcSEcCtD
Rosiglitazone—Back pain—Lisinopril—systemic scleroderma	0.000495	0.00256	CcSEcCtD
Rosiglitazone—Rash—Pentoxifylline—systemic scleroderma	0.00049	0.00254	CcSEcCtD
Rosiglitazone—Hypertension—Mycophenolic acid—systemic scleroderma	0.00049	0.00254	CcSEcCtD
Rosiglitazone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00049	0.00254	CcSEcCtD
Rosiglitazone—Headache—Pentoxifylline—systemic scleroderma	0.000487	0.00252	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000486	0.00252	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000485	0.00251	CcSEcCtD
Rosiglitazone—Myalgia—Mycophenolic acid—systemic scleroderma	0.000483	0.0025	CcSEcCtD
Rosiglitazone—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000483	0.0025	CcSEcCtD
Rosiglitazone—Infection—Leflunomide—systemic scleroderma	0.000483	0.0025	CcSEcCtD
Rosiglitazone—Asthenia—Mometasone—systemic scleroderma	0.000481	0.00249	CcSEcCtD
Rosiglitazone—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00249	CcSEcCtD
Rosiglitazone—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000478	0.00247	CcSEcCtD
Rosiglitazone—Nervous system disorder—Leflunomide—systemic scleroderma	0.000476	0.00247	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000476	0.00246	CcSEcCtD
Rosiglitazone—Pruritus—Mometasone—systemic scleroderma	0.000475	0.00246	CcSEcCtD
Rosiglitazone—Anaemia—Lisinopril—systemic scleroderma	0.000473	0.00245	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—systemic scleroderma	0.000469	0.00243	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000469	0.00243	CcSEcCtD
Rosiglitazone—Angioedema—Lisinopril—systemic scleroderma	0.000467	0.00242	CcSEcCtD
Rosiglitazone—Oedema—Mycophenolic acid—systemic scleroderma	0.000463	0.0024	CcSEcCtD
Rosiglitazone—Nausea—Pentoxifylline—systemic scleroderma	0.000462	0.00239	CcSEcCtD
Rosiglitazone—Infection—Mycophenolic acid—systemic scleroderma	0.00046	0.00238	CcSEcCtD
Rosiglitazone—Diarrhoea—Mometasone—systemic scleroderma	0.000459	0.00238	CcSEcCtD
Rosiglitazone—Leukopenia—Lisinopril—systemic scleroderma	0.000458	0.00237	CcSEcCtD
Rosiglitazone—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000454	0.00235	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000454	0.00235	CcSEcCtD
Rosiglitazone—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000448	0.00232	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000444	0.0023	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000443	0.00229	CcSEcCtD
Rosiglitazone—Arthralgia—Lisinopril—systemic scleroderma	0.000435	0.00226	CcSEcCtD
Rosiglitazone—Myalgia—Lisinopril—systemic scleroderma	0.000435	0.00226	CcSEcCtD
Rosiglitazone—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00224	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00043	0.00223	CcSEcCtD
Rosiglitazone—Rash—Mometasone—systemic scleroderma	0.000423	0.00219	CcSEcCtD
Rosiglitazone—Asthenia—Captopril—systemic scleroderma	0.000423	0.00219	CcSEcCtD
Rosiglitazone—Dermatitis—Mometasone—systemic scleroderma	0.000423	0.00219	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000422	0.00219	CcSEcCtD
Rosiglitazone—Headache—Mometasone—systemic scleroderma	0.00042	0.00218	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000419	0.00217	CcSEcCtD
Rosiglitazone—Fatigue—Leflunomide—systemic scleroderma	0.000419	0.00217	CcSEcCtD
Rosiglitazone—Oedema—Lisinopril—systemic scleroderma	0.000417	0.00216	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000417	0.00216	CcSEcCtD
Rosiglitazone—Pruritus—Captopril—systemic scleroderma	0.000417	0.00216	CcSEcCtD
Rosiglitazone—Constipation—Leflunomide—systemic scleroderma	0.000415	0.00215	CcSEcCtD
Rosiglitazone—Infection—Lisinopril—systemic scleroderma	0.000415	0.00215	CcSEcCtD
Rosiglitazone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00215	CcSEcCtD
Rosiglitazone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00212	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000409	0.00212	CcSEcCtD
Rosiglitazone—Diarrhoea—Captopril—systemic scleroderma	0.000403	0.00209	CcSEcCtD
Rosiglitazone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00208	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.0004	0.00207	CcSEcCtD
Rosiglitazone—Fatigue—Mycophenolic acid—systemic scleroderma	0.0004	0.00207	CcSEcCtD
Rosiglitazone—Nausea—Mometasone—systemic scleroderma	0.000399	0.00206	CcSEcCtD
Rosiglitazone—Weight increased—Prednisone—systemic scleroderma	0.000397	0.00205	CcSEcCtD
Rosiglitazone—Constipation—Mycophenolic acid—systemic scleroderma	0.000396	0.00205	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Prednisone—systemic scleroderma	0.000393	0.00204	CcSEcCtD
Rosiglitazone—Dizziness—Captopril—systemic scleroderma	0.00039	0.00202	CcSEcCtD
Rosiglitazone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000387	0.002	CcSEcCtD
Rosiglitazone—Urticaria—Leflunomide—systemic scleroderma	0.000386	0.002	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000383	0.00198	CcSEcCtD
Rosiglitazone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00198	CcSEcCtD
Rosiglitazone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00198	CcSEcCtD
Rosiglitazone—Myocardial infarction—Prednisone—systemic scleroderma	0.000381	0.00197	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00038	0.00197	CcSEcCtD
Rosiglitazone—Rash—Captopril—systemic scleroderma	0.000372	0.00192	CcSEcCtD
Rosiglitazone—Dermatitis—Captopril—systemic scleroderma	0.000371	0.00192	CcSEcCtD
Rosiglitazone—Headache—Captopril—systemic scleroderma	0.000369	0.00191	CcSEcCtD
Rosiglitazone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00189	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00189	CcSEcCtD
Rosiglitazone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00188	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00036	0.00187	CcSEcCtD
Rosiglitazone—Fatigue—Lisinopril—systemic scleroderma	0.00036	0.00186	CcSEcCtD
Rosiglitazone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00186	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000358	0.00185	CcSEcCtD
Rosiglitazone—Constipation—Lisinopril—systemic scleroderma	0.000357	0.00185	CcSEcCtD
Rosiglitazone—Diarrhoea—Azathioprine—systemic scleroderma	0.000352	0.00182	CcSEcCtD
Rosiglitazone—Nausea—Captopril—systemic scleroderma	0.00035	0.00181	CcSEcCtD
Rosiglitazone—Asthenia—Leflunomide—systemic scleroderma	0.000349	0.00181	CcSEcCtD
Rosiglitazone—Pruritus—Leflunomide—systemic scleroderma	0.000344	0.00178	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000343	0.00178	CcSEcCtD
Rosiglitazone—Dizziness—Azathioprine—systemic scleroderma	0.00034	0.00176	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000339	0.00175	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00173	CcSEcCtD
Rosiglitazone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000332	0.00172	CcSEcCtD
Rosiglitazone—Diarrhoea—Leflunomide—systemic scleroderma	0.000332	0.00172	CcSEcCtD
Rosiglitazone—Urticaria—Lisinopril—systemic scleroderma	0.000332	0.00172	CcSEcCtD
Rosiglitazone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000328	0.0017	CcSEcCtD
Rosiglitazone—Eye disorder—Prednisone—systemic scleroderma	0.000326	0.00169	CcSEcCtD
Rosiglitazone—Rash—Azathioprine—systemic scleroderma	0.000324	0.00168	CcSEcCtD
Rosiglitazone—Dermatitis—Azathioprine—systemic scleroderma	0.000324	0.00168	CcSEcCtD
Rosiglitazone—Headache—Azathioprine—systemic scleroderma	0.000322	0.00167	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000322	0.00167	CcSEcCtD
Rosiglitazone—Dizziness—Leflunomide—systemic scleroderma	0.000321	0.00166	CcSEcCtD
Rosiglitazone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000317	0.00164	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00164	CcSEcCtD
Rosiglitazone—Immune system disorder—Prednisone—systemic scleroderma	0.000315	0.00163	CcSEcCtD
Rosiglitazone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00162	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000307	0.00159	CcSEcCtD
Rosiglitazone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000306	0.00159	CcSEcCtD
Rosiglitazone—Rash—Leflunomide—systemic scleroderma	0.000306	0.00159	CcSEcCtD
Rosiglitazone—Dermatitis—Leflunomide—systemic scleroderma	0.000306	0.00158	CcSEcCtD
Rosiglitazone—Nausea—Azathioprine—systemic scleroderma	0.000306	0.00158	CcSEcCtD
Rosiglitazone—Headache—Leflunomide—systemic scleroderma	0.000304	0.00158	CcSEcCtD
Rosiglitazone—Malnutrition—Prednisone—systemic scleroderma	0.000304	0.00157	CcSEcCtD
Rosiglitazone—Asthenia—Lisinopril—systemic scleroderma	0.000299	0.00155	CcSEcCtD
Rosiglitazone—Pruritus—Lisinopril—systemic scleroderma	0.000295	0.00153	CcSEcCtD
Rosiglitazone—Rash—Mycophenolic acid—systemic scleroderma	0.000292	0.00151	CcSEcCtD
Rosiglitazone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000292	0.00151	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—systemic scleroderma	0.000292	0.00151	CcSEcCtD
Rosiglitazone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000291	0.0015	CcSEcCtD
Rosiglitazone—Headache—Mycophenolic acid—systemic scleroderma	0.00029	0.0015	CcSEcCtD
Rosiglitazone—Nausea—Leflunomide—systemic scleroderma	0.000289	0.00149	CcSEcCtD
Rosiglitazone—Diarrhoea—Lisinopril—systemic scleroderma	0.000286	0.00148	CcSEcCtD
Rosiglitazone—Anaemia—Prednisone—systemic scleroderma	0.000281	0.00145	CcSEcCtD
Rosiglitazone—Angioedema—Prednisone—systemic scleroderma	0.000278	0.00144	CcSEcCtD
Rosiglitazone—Dizziness—Lisinopril—systemic scleroderma	0.000276	0.00143	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000276	0.00143	CcSEcCtD
Rosiglitazone—Nausea—Mycophenolic acid—systemic scleroderma	0.000275	0.00143	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—systemic scleroderma	0.000273	0.00141	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000271	0.0014	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—systemic scleroderma	0.000263	0.00136	CcSEcCtD
Rosiglitazone—Rash—Lisinopril—systemic scleroderma	0.000263	0.00136	CcSEcCtD
Rosiglitazone—Dermatitis—Lisinopril—systemic scleroderma	0.000263	0.00136	CcSEcCtD
Rosiglitazone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00136	CcSEcCtD
Rosiglitazone—Hypertension—Prednisone—systemic scleroderma	0.000262	0.00136	CcSEcCtD
Rosiglitazone—Headache—Lisinopril—systemic scleroderma	0.000261	0.00135	CcSEcCtD
Rosiglitazone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00134	CcSEcCtD
Rosiglitazone—Arthralgia—Prednisone—systemic scleroderma	0.000259	0.00134	CcSEcCtD
Rosiglitazone—Myalgia—Prednisone—systemic scleroderma	0.000259	0.00134	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—systemic scleroderma	0.000254	0.00131	CcSEcCtD
Rosiglitazone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00025	0.0013	CcSEcCtD
Rosiglitazone—Nausea—Lisinopril—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Rosiglitazone—Oedema—Prednisone—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000248	0.00128	CcSEcCtD
Rosiglitazone—Infection—Prednisone—systemic scleroderma	0.000246	0.00128	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—systemic scleroderma	0.000246	0.00127	CcSEcCtD
Rosiglitazone—Nervous system disorder—Prednisone—systemic scleroderma	0.000243	0.00126	CcSEcCtD
Rosiglitazone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00125	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—systemic scleroderma	0.000235	0.00122	CcSEcCtD
Rosiglitazone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000231	0.00119	CcSEcCtD
Rosiglitazone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00119	CcSEcCtD
Rosiglitazone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00119	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—systemic scleroderma	0.000227	0.00118	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000226	0.00117	CcSEcCtD
Rosiglitazone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00113	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—systemic scleroderma	0.000216	0.00112	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—systemic scleroderma	0.000216	0.00112	CcSEcCtD
Rosiglitazone—Fatigue—Prednisone—systemic scleroderma	0.000214	0.00111	CcSEcCtD
Rosiglitazone—Constipation—Prednisone—systemic scleroderma	0.000212	0.0011	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000207	0.00107	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—systemic scleroderma	0.000206	0.00107	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—systemic scleroderma	0.000203	0.00105	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000203	0.00105	CcSEcCtD
Rosiglitazone—Urticaria—Prednisone—systemic scleroderma	0.000197	0.00102	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000189	0.000978	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000179	0.000926	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—systemic scleroderma	0.000179	0.000925	CcSEcCtD
Rosiglitazone—Asthenia—Prednisone—systemic scleroderma	0.000178	0.000921	CcSEcCtD
Rosiglitazone—Pruritus—Prednisone—systemic scleroderma	0.000175	0.000908	CcSEcCtD
Rosiglitazone—Diarrhoea—Prednisone—systemic scleroderma	0.00017	0.000878	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—systemic scleroderma	0.000165	0.000852	CcSEcCtD
Rosiglitazone—Dizziness—Prednisone—systemic scleroderma	0.000164	0.000849	CcSEcCtD
Rosiglitazone—Rash—Prednisone—systemic scleroderma	0.000156	0.00081	CcSEcCtD
Rosiglitazone—Dermatitis—Prednisone—systemic scleroderma	0.000156	0.000809	CcSEcCtD
Rosiglitazone—Headache—Prednisone—systemic scleroderma	0.000155	0.000804	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—systemic scleroderma	0.000149	0.00077	CcSEcCtD
Rosiglitazone—Nausea—Prednisone—systemic scleroderma	0.000147	0.000763	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—systemic scleroderma	0.000147	0.000759	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—systemic scleroderma	0.000142	0.000734	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—systemic scleroderma	0.000137	0.00071	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—systemic scleroderma	0.000131	0.000677	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—systemic scleroderma	0.000131	0.000676	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—systemic scleroderma	0.00013	0.000672	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—systemic scleroderma	0.000123	0.000637	CcSEcCtD
